Header Logo

Connection

Amanda Petrik to Humans

Back to Details
This is a "connection" page, showing publications Amanda Petrik has written about Humans.
Amanda Petrik
Connection Strength
0.815
Humans
  1. A qualitative assessment of the acceptability of human papillomavirus self-sampling and informational materials among diverse populations. Cancer Med. 2024 Jul; 13(14):e70033.
    View in: PubMed
    Score: 0.067
  2. Data Challenges in Identifying Patients Due for Colorectal Cancer Screening in Rural Clinics. J Am Board Fam Med. 2023 Feb 08; 36(1):118-129.
    View in: PubMed
    Score: 0.061
  3. Development of a multivariable prediction model to identify patients unlikely to complete a colonoscopy following an abnormal FIT test in community clinics. BMC Health Serv Res. 2020 Nov 10; 20(1):1028.
    View in: PubMed
    Score: 0.052
  4. Factors Influencing Implementation of a Colorectal Cancer Screening Improvement Program in Community Health Centers: an Applied Use of Configurational Comparative Methods. J Gen Intern Med. 2020 11; 35(Suppl 2):815-822.
    View in: PubMed
    Score: 0.052
  5. Predictors of Colorectal Cancer Screening Prior to Implementation of a Large Pragmatic Trial in Federally Qualified Health Centers. J Community Health. 2018 02; 43(1):128-136.
    View in: PubMed
    Score: 0.043
  6. The validation of electronic health records in accurately identifying patients eligible for colorectal cancer screening in safety net clinics. Fam Pract. 2016 12; 33(6):639-643.
    View in: PubMed
    Score: 0.039
  7. Integrating clinical trial findings into practice through risk stratification: the case of heart failure management. Popul Health Manag. 2010 Jun; 13(3):123-9.
    View in: PubMed
    Score: 0.025
  8. Harmonizing data across the accelerating colorectal cancer screening and follow-up through implementation science (ACCSIS) program to enhance data quality and promote data sharing. BMC Health Serv Res. 2024 Nov 06; 24(1):1356.
    View in: PubMed
    Score: 0.017
  9. Evaluating the Reach of a Patient Navigation Program for Follow-up Colonoscopy in a Large Federally Qualified Health Center. Cancer Prev Res (Phila). 2024 Jul 02; 17(7):325-333.
    View in: PubMed
    Score: 0.017
  10. Effort Required and Lessons Learned From Recruiting Health Plans and Rural Primary Care Practices for a Cancer Screening Outreach Study. J Prim Care Community Health. 2024 Jan-Dec; 15:21501319241259915.
    View in: PubMed
    Score: 0.016
  11. Effectiveness and Cost of an Enhanced Mailed Fecal Test Outreach Colorectal Cancer Screening Program: Findings from the PROMPT Stepped-Wedge Trial. Cancer Epidemiol Biomarkers Prev. 2023 11 01; 32(11):1608-1616.
    View in: PubMed
    Score: 0.016
  12. The Cancer Financial Experience (CAFÉ) study: randomized controlled trial of a financial navigation intervention to address cancer-related financial hardship. Trials. 2022 May 13; 23(1):402.
    View in: PubMed
    Score: 0.014
  13. Clinic Factors Associated With Mailed Fecal Immunochemical Test (FIT) Completion: The Difference-Making Role of Support Staff. Ann Fam Med. 2022 Mar-Apr; 20(2):123-129.
    View in: PubMed
    Score: 0.014
  14. Colonoscopy Following an Abnormal Fecal Test Result from an Annual Colorectal Cancer Screening Program in a Federally Qualified Health Center. J Prim Care Community Health. 2022 Jan-Dec; 13:21501319221138423.
    View in: PubMed
    Score: 0.014
  15. Follow-up colonoscopy after an abnormal stool-based colorectal cancer screening result: analysis of steps in the colonoscopy completion process. BMC Gastroenterol. 2021 Sep 28; 21(1):356.
    View in: PubMed
    Score: 0.014
  16. The influence of multi-morbidities on colorectal cancer screening recommendations and completion. Cancer Causes Control. 2021 May; 32(5):555-565.
    View in: PubMed
    Score: 0.013
  17. Barriers and Facilitators to Timely Colonoscopy Completion for Safety Net Clinic Patients. Am J Health Behav. 2020 07 01; 44(4):460-472.
    View in: PubMed
    Score: 0.013
  18. First-year implementation of mailed FIT colorectal cancer screening programs in two Medicaid/Medicare health insurance plans: qualitative learnings from health plan quality improvement staff and leaders. BMC Health Serv Res. 2020 Feb 21; 20(1):132.
    View in: PubMed
    Score: 0.012
  19. Prospective Cohort study of Predictors of Follow-Up Diagnostic Colonoscopy from a Pragmatic Trial of FIT Screening. Sci Rep. 2020 02 12; 10(1):2441.
    View in: PubMed
    Score: 0.012
  20. Moderators of the effectiveness of an intervention to increase colorectal cancer screening through mailed fecal immunochemical test kits: results from a pragmatic randomized trial. Trials. 2020 Jan 15; 21(1):91.
    View in: PubMed
    Score: 0.012
  21. Patient randomized trial of a targeted navigation program to improve rates of follow-up colonoscopy in community health centers. Contemp Clin Trials. 2020 02; 89:105920.
    View in: PubMed
    Score: 0.012
  22. Direct-to-member mailed colorectal cancer screening outreach for Medicaid and Medicare enrollees: Implementation and effectiveness outcomes from the BeneFIT study. Cancer. 2020 02 01; 126(3):540-548.
    View in: PubMed
    Score: 0.012
  23. Patient-Refined Messaging for a Mailed Colorectal Cancer Screening Program: Findings from the PROMPT Study. J Am Board Fam Med. 2019 May-Jun; 32(3):318-328.
    View in: PubMed
    Score: 0.012
  24. A Survey of Provider Attitudes, Beliefs, and Perceived Barriers Regarding a Centralized Direct-Mail Colorectal Cancer Screening Approach at Community Health Centers. J Prim Care Community Health. 2019 Jan-Dec; 10:2150132719890950.
    View in: PubMed
    Score: 0.011
  25. Implementation successes and challenges in participating in a pragmatic study to improve colon cancer screening: perspectives of health center leaders. Transl Behav Med. 2017 09; 7(3):557-566.
    View in: PubMed
    Score: 0.010
  26. Applying the Plan-Do-Study-Act (PDSA) approach to a large pragmatic study involving safety net clinics. BMC Health Serv Res. 2017 06 19; 17(1):411.
    View in: PubMed
    Score: 0.010
  27. Predicting 5-Year Risk of RRT in Stage 3 or 4 CKD: Development and External Validation. Clin J Am Soc Nephrol. 2017 01 06; 12(1):87-94.
    View in: PubMed
    Score: 0.010
  28. Timeliness of Colonoscopy After Abnormal Fecal Test Results in a Safety Net Practice. J Community Health. 2016 08; 41(4):864-70.
    View in: PubMed
    Score: 0.010
  29. Predicting the Risk of Clostridium difficile Infection upon Admission: A Score to Identify Patients for Antimicrobial Stewardship Efforts. Perm J. 2016; 20(1):20-5.
    View in: PubMed
    Score: 0.009
  30. Systolic BP and Mortality in Older Adults with CKD. Clin J Am Soc Nephrol. 2015 Sep 04; 10(9):1553-9.
    View in: PubMed
    Score: 0.009
  31. Predicting mortality in older adults with kidney disease: a pragmatic prediction model. J Am Geriatr Soc. 2015 Mar; 63(3):508-15.
    View in: PubMed
    Score: 0.009
  32. Predicting the risk of Clostridium difficile infection following an outpatient visit: development and external validation of a pragmatic, prognostic risk score. Clin Microbiol Infect. 2015 Mar; 21(3):256-62.
    View in: PubMed
    Score: 0.009
  33. Clinical perspectives on colorectal cancer screening at Latino-serving federally qualified health centers. Health Educ Behav. 2015 Feb; 42(1):26-31.
    View in: PubMed
    Score: 0.008
  34. Strategies and Opportunities to STOP Colon Cancer in Priority Populations: design of a cluster-randomized pragmatic trial. Contemp Clin Trials. 2014 Jul; 38(2):344-9.
    View in: PubMed
    Score: 0.008
  35. Individuality of the plasma sodium concentration. Am J Physiol Renal Physiol. 2014 Jun 15; 306(12):F1534-43.
    View in: PubMed
    Score: 0.008
  36. Advantages of wordless instructions on how to complete a fecal immunochemical test: lessons from patient advisory council members of a federally qualified health center. J Cancer Educ. 2014 Mar; 29(1):86-90.
    View in: PubMed
    Score: 0.008
  37. Strategies and opportunities to STOP colon cancer in priority populations: pragmatic pilot study design and outcomes. BMC Cancer. 2014 Feb 26; 14:55.
    View in: PubMed
    Score: 0.008
  38. Perceptions of under and overutilization of cervical cancer screening services at Latino-serving community health centers. J Community Health. 2013 Oct; 38(5):915-8.
    View in: PubMed
    Score: 0.008
  39. Prescription opioids for back pain and use of medications for erectile dysfunction. Spine (Phila Pa 1976). 2013 May 15; 38(11):909-15.
    View in: PubMed
    Score: 0.008
  40. Predicting costs of care in heart failure patients. BMC Health Serv Res. 2012 Nov 30; 12:434.
    View in: PubMed
    Score: 0.007
  41. Clinician's use of automated reports of estimated glomerular filtration rate: a qualitative study. BMC Nephrol. 2012 Nov 23; 13:154.
    View in: PubMed
    Score: 0.007
  42. Correlates of higher-dose opioid medication use for low back pain in primary care. J Pain. 2012 Nov; 13(11):1131-8.
    View in: PubMed
    Score: 0.007
  43. Should measuring haemoglobin among chronic kidney disease patients be a performance measure? J Evid Based Med. 2012 Nov; 5(4):194-204.
    View in: PubMed
    Score: 0.007
  44. Epidemiology and healthcare costs of incident Clostridium difficile infections identified in the outpatient healthcare setting. Infect Control Hosp Epidemiol. 2012 Oct; 33(10):1031-8.
    View in: PubMed
    Score: 0.007
  45. Clostridium difficile infection, Colorado and the northwestern United States, 2007. Emerg Infect Dis. 2012 Jun; 18(6):960-2.
    View in: PubMed
    Score: 0.007
  46. Proteinuria among patients with chronic kidney disease: a performance measure for improving patient outcomes. Jt Comm J Qual Patient Saf. 2012 Jun; 38(6):277-82.
    View in: PubMed
    Score: 0.007
  47. Predicting chronic kidney disease outcomes: are two estimated glomerular filtration rates better than one? Popul Health Manag. 2012 Apr; 15(2):113-8.
    View in: PubMed
    Score: 0.007
  48. Opioids for back pain patients: primary care prescribing patterns and use of services. J Am Board Fam Med. 2011 Nov-Dec; 24(6):717-27.
    View in: PubMed
    Score: 0.007
  49. An economic evaluation of a laboratory monitoring program for renin-angiotensin system agents. Med Decis Making. 2011 Mar-Apr; 31(2):315-24.
    View in: PubMed
    Score: 0.007
  50. Systolic blood pressure and mortality among older community-dwelling adults with CKD. Am J Kidney Dis. 2010 Dec; 56(6):1062-71.
    View in: PubMed
    Score: 0.006
  51. Predicting the risk of hyperkalemia in patients with chronic kidney disease starting lisinopril. Pharmacoepidemiol Drug Saf. 2010 Mar; 19(3):266-72.
    View in: PubMed
    Score: 0.006
  52. Outcomes predicted by phosphorous in chronic kidney disease: a retrospective CKD-inception cohort study. Nephrol Dial Transplant. 2010 Jan; 25(1):166-74.
    View in: PubMed
    Score: 0.006
  53. Comparison of renal replacement therapy and mortality using 1 versus 2 estimated glomerular filtration rates. Popul Health Manag. 2009 Jun; 12(3):149-55.
    View in: PubMed
    Score: 0.006
  54. Effect of anaemia on mortality, cardiovascular hospitalizations and end-stage renal disease among patients with chronic kidney disease. Nephrology (Carlton). 2009 Apr; 14(2):240-6.
    View in: PubMed
    Score: 0.006
  55. An outreach program improved osteoporosis management after a fracture. J Am Geriatr Soc. 2007 Sep; 55(9):1464-9.
    View in: PubMed
    Score: 0.005
  56. Using web-based screening to enhance efficiency of HMO clinical trial recruitment in women aged forty and older. Clin Trials. 2007; 4(1):102-5.
    View in: PubMed
    Score: 0.005

© 2025 Kaiser Permanente